Kairos Pharma, Ltd.
USD0.37
+0.01 (+3.11%)
CEO
John S. Yu
IPO Date
2024-09-16
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
Open
$0.35
Prev. Close
$0.36
Day Low
$0.35
Day High
$0.38
52W Low
$0.33
52W High
$2.11
Market Cap
$0.01B
Volume
0.03M
| -6.6 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 87.2% | -187.8% | -0.31 | 0.04 | -14.9 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 89.1% | -101.4% | -0.50 | 0.27 | -25.3 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 183.8% | -276.8% | -0.33 | 0.04 | -15.6 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 306.7% | -7348.0% | -0.15 | 0.04 | -27.7 |
| -2.4 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -18.2% | -17.3% | 0.00 | 16.56 | -4.2 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -23.7% | -21.3% | 0.00 | 7.16 | -2.1 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -17.7% | -15.9% | 0.00 | 7.52 | -2.9 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -20.5% | -15.8% | 0.00 | 4.20 | -5.3 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -31.4% | -20.9% | 0.04 | 2.84 | -4.1 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 9.5% | -24.6% | -0.30 | 0.01 | -33.0 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | 13.5% | -33.2% | -0.28 | 0.02 | -21.3 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 53.8% | -115.9% | -0.31 | 0.04 | -6.1 |